OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT
OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT
批准号:
6443558
负责人:
MICHAEL P MCGROGAN
金额:
$47.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-10 至 2003-08-31
中文摘要
描述(申请人提供):HNT-神经元是纯人类神经细胞,表现出神经元表型,并有效地植入
移植到啮齿动物的脊髓内。第一阶段研究成功开展
具有适合脊髓移植的特性的HNT神经元,
确定了最大限度提高移植物成功率的关键实验条件
活体,并证明了移植物在啮齿动物模型中的存活与临床相关
颈髓挫伤。第二阶段的研究将集中于进一步
产品开发,嫁接方案的优化,以及密集
长期安全性和安全性的解剖学、神经生理学和行为学研究
功效。具体目标包括:(1)检查移植物存活率、细胞率
分化、神经递质表型特征与神经元性生长
作为移植的HNT神经元的细胞密度的函数;以及(2)建立
通过监测安全状况来实现长期的安全性和功能性功效,
膈运动神经元功能和延长时间后的前肢运动行为
脊髓挫伤后移植HNT神经元的时间。这个
这些实验的结果将有助于建立治疗的潜力
HNT-神经元改善脊髓损伤预后并提供有价值的
推进临床试验所需的信息。
建议的商业应用:
不可用
英文摘要
DESCRIPTION (provided by applicant): hNT-Neurons are pure human neuronal cells that exhibit neuronal phenotypes and efficiently engraft following
transplantation into rodent spinal cord. Phase I studies successfully developed
hNT-Neurons with properties suitable for spinal cord transplantation,
identified the critical experimental conditions to maximize graft success in
vivo, and demonstrated graft survival in a rodent model of clinically relevant
cervical spinal cord contusion injury. Phase II studies will focus on further
product development, optimization of grafting protocols, and intensive
anatomical, neurophysiological and behavioral studies of long-term safety and
efficacy. Specific aims include: (1) examine graft survival, rate of cellular
differentiation, neurotransmitter phenotypic profiles, and neuritic outgrowth
as a function of the cell density of grafted hNT-Neurons; and (2) establish
long-term safety and functional efficacy by monitoring the safety profile,
phrenic motoneuron function, and forelimb motor behavior over extended time
periods following grafts of hNT-Neurons in spinal cord contusion injury. The
results of these experiments will help establish the therapeutic potential of
hNT-Neurons to improve outcomes in spinal cord injury and provide valuable
information necessary to move ahead toward clinical trials.
PROPOSED COMMERCIAL APPLICATION:
Not Available
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRODUCING HUMAN NEURONAL CELLS TO TREAT STROKE
-
批准号:6071782
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2000
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS
-
批准号:6522617
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2000
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT
-
批准号:6529414
-
项目类别:
-
资助金额:$48.78万
-
财政年份:1999
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT
-
批准号:2870404
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
HUMAN NEURONAL CELL THERAPY FOR PARKINSONS DISEASE
-
批准号:2714636
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1997
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
HUMAN NEURONAL CELL THERAPY FOR PARKINSONS DISEASE
-
批准号:2892260
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1997
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
NEURONAL CELL THERAPY FOR PARKINSONS DISEASE
-
批准号:2039209
-
项目类别:
-
资助金额:$9.94万
-
财政年份:1997
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
PROTEASE NEXIN I
-
批准号:3497855
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1987
-
负责人:MICHAEL P MCGROGAN
-
依托单位:
海外基金